GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 783 filers reported holding GLAXOSMITHKLINE PLC in Q2 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $16,000 | -100.0% | 390 | -100.0% | 0.00% | -100.0% |
| Q4 2016 | $33,500,000 | -19.2% | 869,904 | -9.5% | 0.26% | -18.4% |
| Q3 2016 | $41,476,000 | -6.7% | 961,656 | -6.2% | 0.32% | -8.1% |
| Q2 2016 | $44,441,000 | +208.6% | 1,025,410 | +188.7% | 0.34% | +258.3% |
| Q1 2016 | $14,400,000 | +2.9% | 355,126 | +2.4% | 0.10% | +7.9% |
| Q4 2015 | $14,000,000 | +1.6% | 346,959 | -3.2% | 0.09% | +3.5% |
| Q3 2015 | $13,775,000 | -8.7% | 358,260 | -1.1% | 0.09% | -1.1% |
| Q2 2015 | $15,082,000 | -72.1% | 362,113 | -69.1% | 0.09% | -71.1% |
| Q1 2015 | $54,056,000 | +367.9% | 1,171,305 | +333.3% | 0.30% | +419.0% |
| Q4 2014 | $11,552,000 | -27.2% | 270,292 | -21.7% | 0.06% | -19.4% |
| Q3 2014 | $15,861,000 | +2.5% | 345,032 | +19.2% | 0.07% | +16.1% |
| Q2 2014 | $15,476,000 | – | 289,373 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |